Stock detail
Roivant Sciences (ROIV) stock price, chart, and key data
View Roivant Sciences stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Roivant Sciences
ROIV · XNAS
$40.67
-2.73%
-$1.14
Key metrics
52-week range
$5.00 - $27.00
Close price
$41.81
Market cap
$30.2B
P/E ratio
-107.21
Beta
3.2
About the company
Roivant Sciences Ltd
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$45.56
7
Buy
/ 8
Recent calls
09/08/2026
Guggenheim
Yatin Suneja
Buy · Price target $46.00
09/09/2026
TD Cowen
Yaron Werber
Buy · Price target $55.00
09/09/2026
H.C. Wainwright
Douglas Tsao
Buy · Price target $47.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Rick McCartney self |
| 46/368/691 |
#2Lisa McClain republican · House · MI-9 spouse |
| 39/319/599 |
#3Donald J Trump republican · Executive self |
| 23/191/358 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app